Loading...
XNAS
MMSI
Market cap5.84bUSD
May 20, Last price  
98.81USD
1D
0.72%
1Q
-7.14%
Jan 2017
272.87%
Name

Merit Medical Systems Inc

Chart & Performance

D1W1MN
XNAS:MMSI chart
No data to show
P/E
48.52
P/S
4.30
EPS
2.04
Div Yield, %
Shrs. gr., 5y
1.09%
Rev. gr., 5y
6.40%
Revenues
1.36b
+7.89%
166,585,000190,674,000207,768,000227,143,000257,462,000296,755,000359,449,000394,288,000449,049,000509,689,000542,149,000603,838,000727,852,000882,753,000994,852,000963,875,0001,074,751,0001,150,981,0001,257,366,0001,356,514,000
Net income
120m
+27.48%
15,778,00012,301,00015,588,00020,727,00022,530,00012,460,00023,044,00019,710,00016,570,00022,974,00023,802,00020,121,00027,523,00042,017,0005,451,000-9,843,00048,454,00074,516,00094,411,000120,357,000
CFO
221m
+52.12%
11,094,00019,106,00032,119,00027,967,00030,070,00034,760,00034,015,00046,938,00051,373,00053,325,00069,458,00053,599,00062,727,00086,533,00077,813,000165,270,000147,231,000114,291,000145,151,000220,799,000
Earnings
Jul 30, 2025

Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
IPO date
Sep 16, 1954
Employees
6,846
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,356,514
7.89%
1,257,366
9.24%
1,150,981
7.09%
Cost of revenue
796,993
756,222
707,392
Unusual Expense (Income)
NOPBT
559,521
501,144
443,589
NOPBT Margin
41.25%
39.86%
38.54%
Operating Taxes
29,636
17,678
8,113
Tax Rate
5.30%
3.53%
1.83%
NOPAT
529,885
483,466
435,476
Net income
120,357
27.48%
94,411
26.70%
74,516
53.79%
Dividends
Dividend yield
Proceeds from repurchase of equity
40,908
15,584
17,596
BB yield
-0.71%
-0.35%
-0.43%
Debt
Debt current
10,331
12,087
22,255
Long-term debt
864,899
947,618
317,236
Deferred revenue
1,502
1,605
1,708
Other long-term liabilities
21,315
33,256
32,259
Net debt
475,683
351,508
265,507
Cash flow
Cash from operating activities
220,799
145,151
114,291
CAPEX
(36,701)
(45,029)
Cash from investing activities
(368,653)
(175,347)
(57,397)
Cash from financing activities
(60,008)
559,266
(60,260)
FCF
513,245
420,564
350,174
Balance
Cash
376,715
589,136
58,408
Long term investments
22,832
19,061
15,576
Excess cash
331,721
545,329
16,435
Stockholders' equity
1,379,359
1,202,000
1,144,397
Invested Capital
1,880,571
1,582,891
1,423,982
ROIC
30.60%
32.16%
31.19%
ROCE
25.29%
23.49%
30.41%
EV
Common stock shares outstanding
59,365
58,356
57,671
Price
96.72
27.33%
75.96
7.56%
70.62
13.35%
Market cap
5,741,783
29.53%
4,432,722
8.84%
4,072,726
13.97%
EV
6,217,466
4,784,230
4,338,233
EBITDA
674,253
602,436
535,787
EV/EBITDA
9.22
7.94
8.10
Interest
31,219
15,511
6,339
Interest/NOPBT
5.58%
3.10%
1.43%